Abstract
This study synthesized a series of carbazole compounds and tested their antimicrobial activity. Several of the synthesized compounds demonstrated potent inhibitory effects against Gram-negative bacteria. Molecular docking simulations with the fatty acid synthesis enzyme FabH revealed their potential antimicrobial action by interfering with fatty acid synthesis. Additionally, ADMET analysis confirmed favorable pharmacokinetic properties, providing a foundation for drug development and preclinical research. Furthermore, the optimized compound 2-(9HCarbazol-9-yl)-N-(4-(trifluoromethoxy)phenyl)acetamide was evaluated for its inhibitory and disruptive effects on biofilms using live/dead cell staining. The results demonstrated significant inhibition and disruption of biofilms, enhancing their antimicrobial efficacy. These findings offer valuable clues for the development of new antimicrobial drugs and hold promise for addressing the challenge of antimicrobial resistance with novel therapeutic strategies.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
